Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: Neuroprotective and anti-inflammatory activities

Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: Neuroprotective and anti-inflammatory activities
Pharmacol Res. 2021 Mar 31:105589. doi: 10.1016/j.phrs.2021.105589. Online ahead of print.ABSTRACTThe treatment of Parkinson´s disease (PD) has benefited from significant advances resulting from the increasing research efforts focused on new therapeutics. However, the current treatments for PD are mostly symptomatic, alleviating disease symptoms without reversing or retarding disease progression. Thus, it is critical to find new molecules that can result ... read more
Source: PubMedPublished on 2021-04-03By Joana Silva